FOGHORN THERAPEUTICS I
7.8399
07-أكتوبر-24 10:56:21
15 متأخرة بدقائق
الأسهم
+0.0099
+0.13%
نطاق اليوم
7.5000 - 7.9100
ISIN
N/A
المصدر
NASDAQ
-
Foghorn Therapeutics to Present at Connective Tissue Oncology Society Annual Meeting
14 نوفمبر 2022 06:00:01 بحسب Nasdaq GlobeNewswire
-
09 نوفمبر 2022 06:00:01 بحسب Nasdaq GlobeNewswire
-
Foghorn Therapeutics Provides Third Quarter 2022 Financial and Corporate Update
08 نوفمبر 2022 06:00:01 بحسب Nasdaq GlobeNewswire
-
Foghorn Therapeutics Appoints Dr. Thomas J. Lynch, Jr. to Its Board of Directors
27 أكتوبر 2022 06:00:01 بحسب Nasdaq GlobeNewswire
-
26 أكتوبر 2022 06:00:01 بحسب Nasdaq GlobeNewswire
-
Foghorn Therapeutics to Present at Hanson Wade's 5th Annual Targeted Protein Degradation Summit
20 أكتوبر 2022 06:00:01 بحسب Nasdaq GlobeNewswire
-
Foghorn Therapeutics to Participate in the Bank of America 2022 Precision Oncology Conference
27 سبتمبر 2022 07:00:01 بحسب Nasdaq GlobeNewswire
-
Foghorn Therapeutics Announces Participation in Upcoming Investor Conferences
01 سبتمبر 2022 15:05:00 بحسب Nasdaq GlobeNewswire
-
Foghorn Therapeutics Announces Change to Board of Directors
31 أغسطس 2022 15:05:00 بحسب Nasdaq GlobeNewswire
-
Foghorn Therapeutics Provides Further Update on FHD-286 Phase I Study in Relapsed/Refractory AML/MDS
23 أغسطس 2022 06:00:00 بحسب Nasdaq GlobeNewswire
-
Foghorn Therapeutics Appoints Lynne Parshall to its Board of Directors
17 أغسطس 2022 06:00:01 بحسب Nasdaq GlobeNewswire
-
Foghorn Therapeutics Provides Second Quarter 2022 Financial and Corporate Update
09 أغسطس 2022 06:00:01 بحسب Nasdaq GlobeNewswire
-
Foghorn Therapeutics Announces Upcoming Investor Conference Participation
31 مايو 2022 15:05:00 بحسب Nasdaq GlobeNewswire
-
19 مايو 2022 15:01:00 بحسب Nasdaq GlobeNewswire
-
Foghorn Therapeutics Provides First Quarter 2022 Corporate Update
09 مايو 2022 06:00:01 بحسب Nasdaq GlobeNewswire
-
13 أبريل 2022 10:30:00 بحسب Nasdaq GlobeNewswire
-
Foghorn Therapeutics to Present Preclinical Data For FHD-286 at the 2022 AACR Annual Meeting
01 أبريل 2022 07:00:00 بحسب Nasdaq GlobeNewswire
-
Foghorn Therapeutics to Participate at the 2022 Guggenheim Targeted Protein Degradation Day
11 مارس 2022 15:01:00 بحسب Nasdaq GlobeNewswire
-
Foghorn Therapeutics Provides Full Year 2021 Corporate Update and 2022 Outlook
10 مارس 2022 06:00:01 بحسب Nasdaq GlobeNewswire
-
Foghorn Therapeutics to Participate at the Cowen’s 42nd Annual Health Care Conference
28 فبراير 2022 15:05:01 بحسب Nasdaq GlobeNewswire